ea0065op2.1 | Thyroid | SFEBES2019
Rowse Victoria
, Hussain Shazia
, Trahair Emily
, Drake William
, Siddiqi Ayesha
The amount of radioactivity given to patients undergoing ablation for remnant tissue in thyroid cancer at our centre has been greatly reduced to 1100 MBq I-131 in recent years, prompting a review of practice. An extensive risk assessment, focusing particularly on radiation exposure to the public during the patientÂ’s commute home was conducted and found patients could now be discharged safely on the day of treatment. Owing to these findings and audit showing 86% of patient...